Supplement-drug interactions
This article was originally published in The Tan Sheet
Executive Summary
"Potentially severe drug-dietary supplement interactions were infrequent and comparable in incidence to potentially serious drug-drug interactions" in a population of 458 veteran outpatients from VA centers in Pittsburgh and Los Angeles, according to a study published in the March 22 Archives of Internal Medicine. Of 89 potential drug-supplement interactions identified, 6% were classified as severe, say Catherine Peng, Veterans Affairs Pittsburgh Healthcare System, et al. Most of the potential interactions identified were with ginseng, garlic, ginkgo, and coenzyme Q-10. Authors note 43% of the patients were taking at least one supplement with Rx medications...
You may also be interested in...
US FDA Urges COVID-19 Transmission Risk Mitigation In Cell And Gene Therapy Manufacturing
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
COVID-19: US Acted To Beat Other Countries To Next 1.25M Doses Of Regeneron Cocktail
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.
ViiV Anticipates 10%-15% Switchover To Long-Term HIV Option Cabenuva
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: